Hereditary spherocytosis

Also known as: 유전구형적혈구증 가족성 용혈성 빈혈, 유전성 구상적혈구증

Doctors who treat Hereditary spherocytosis

See all
Soonchunhyang University Seoul Hospital Kim Gyeong-ha

Kim Gyeong-ha

Soonchunhyang University Seoul Hospital · Hematology and Oncology

만성백혈병, 악성림프종, 다발성골수종, 조혈모세포이식, CAR-T 세포치료, 출혈성질환, 혈전클리닉(암 관련 혈전 질환 치료 및 예방), 빈혈, 기타 혈액질환

5.0
Soonchunhyang University Seoul Hospital Yoon Seok-yun

Yoon Seok-yun

Soonchunhyang University Seoul Hospital · Hematology and Oncology

급성백혈병, 골수형성이상증후군, 재생불량성빈혈, 골수증식종양, 조혈모세포이식, 빈혈, 기타 혈액질환, CAR-T 세포치료

5.0
Chungnam National University Hospital Ko Jeong-suk

Ko Jeong-suk

Chungnam National University Hospital · Hematology and Oncology

혈액질환(빈혈, 급성백혈병, 골수형성이상증후군), 골수이식

5.0
Hallym University Sacred Heart Hospital Han Bo-ram

Han Bo-ram

Hallym University Sacred Heart Hospital · Hematology and Oncology

백혈병, 골수형성이상증후군 등 악성혈액질환, 빈혈, 백혈구, 혈소판 감소 등 양성혈액질환

5.0
Yeouido St. Mary's Hospital, Catholic University of Korea Jeon Yeong-u

Jeon Yeong-u

Yeouido St. Mary's Hospital, Catholic University of Korea · Hematology and Oncology

CAR-T세포치료/이중항체치료,림프종,조혈모세포이식,면역세포치료,만성림프구성백혈병,캐슬만,형질세포이상증후군,야간혈색소 혈뇨증 (PNH), (혈액)희귀질환

4.5
Seoul National University Hospital Kim In-ho

Kim In-ho

Seoul National University Hospital · Hematology and Oncology

만성골수성백혈병, 골수형성이상증후군, 다발골수종, 골수섬유화증, 재생불량빈혈

3.3
Asan Medical Center Choi Eun-ji

Choi Eun-ji

Asan Medical Center · Hematology and Oncology

급성·만성골수성백혈병, 골수형성이상증후군, 재생불량성빈혈, 골수증식성종양, 급성백혈병의심,유전성 혈액암 클리닉

Samsung Seoul Hospital Jung Cheol-won

Jung Cheol-won

Samsung Seoul Hospital · Hematology and Oncology

백혈병, 조혈모세포이식, 만성골수증식성질환, 빈혈, 출혈질환

Samsung Seoul Hospital Jang Jun-ho

Jang Jun-ho

Samsung Seoul Hospital · Hematology and Oncology

골수형성이상증후군, 재생불량성빈혈, 혈소판감소증, 발작성야간혈색소뇨증, 급성백혈병, 만성림프구성백혈병, 빈혈

Samsung Seoul Hospital Choi Dae-ho

Choi Dae-ho

Samsung Seoul Hospital · Hematology and Oncology

백혈병, 만성골수증식성질환, 출혈질환, 빈혈, 재생불량성빈혈, 혈소판감소증, 발작성야간혈색소뇨증, 골수형성이상증후군

Confirm disease name

  • This is a medically used term. (Myeloproliferative neoplasm; major subtypes: polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), etc.)

1) Disease Description (Causes and Symptoms)

  • Causes and pathophysiology
    • A group of diseases in which clonal abnormalities of the hematopoietic system cause excessive production of red blood cells, white blood cells, and platelets in the bone marrow.
    • Common genetic mutations: JAK2, CALR, MPL (chronic myeloid leukemia is also associated with the BCR‑ABL fusion gene).
    • As bone marrow fibrosis progresses, normal hematopoiesis is impaired, resulting in compensatory hematopoiesis in the spleen and liver.
  • Main symptoms
    • Thrombosis (arterial and venous), bleeding tendency, splenomegaly, fatigue·malaise, weight loss, fever, night sweats
    • PV: facial flushing, headache, symptoms related to hyperviscosity (increased blood viscosity)
    • ET: platelet-related thrombosis and bleeding, burning sensation in the hands and feet (erythromelalgia)
    • PMF: anemia, splenomegaly (feeling of fullness in the left upper abdomen), systemic symptoms (constitutional symptoms)

2) Treatment Methods and Precautions

  • Treatment goals
    • Prevent thrombosis and bleeding, relieve symptoms, suppress progression (myelofibrosis and transformation to acute leukemia), and improve survival (curative treatment is considered particularly for younger patients)
  • Medication and procedures
    • Thrombosis prevention: low-dose aspirin (decided after assessing the individual bleeding risk)
    • Reducing red blood cell count (PV): repeated phlebotomy + low-dose aspirin if necessary
    • Cytoreductive agent: hydroxyurea — blood cell count control in older and high-risk patients
    • Interferon (pegylated interferon) — a preferred alternative for patients who are pregnant or planning pregnancy and for younger patients
    • Targeted therapy: JAK inhibitors (e.g., ruxolitinib) — mainly for PMF and refractory PV, with the aim of relieving symptoms and reducing spleen size
    • High-risk or progressive disease: allogeneic hematopoietic stem cell transplantation (the only potentially curative option, mainly for young and suitable patients)
    • Emergency and specialized treatment when bleeding or thrombosis occurs, respectively (including anticoagulation and platelet transfusion)
  • Lifestyle management
    • Quit smoking, exercise regularly (be aware of the risk of thrombosis from excessive dehydration and strenuous exercise), and drink sufficient fluids
    • Consult in advance about a plan for anticoagulation and platelet management in the event of infection, surgery, or prolonged hospitalization
  • Precautions and risk of complications
    • Risk of thrombosis (stroke, myocardial infarction, deep vein thrombosis, pulmonary embolism) and bleeding
    • May progress over time to myelofibrosis or acute myeloid leukemia (risk varies by subtype and genetic mutation)
    • Regular monitoring is necessary for medication side effects (bone marrow suppression, abnormal liver function, etc.)

3) Checklist Before an Outpatient Visit (Items to Prepare and Points to Confirm)

  • Items to prepare
    • List of currently taken medications and supplements (including dosage and time of administration)
    • Recent blood test results (CBC, platelets, Hb/Hct, white blood cell count, liver and kidney tests, etc.)
    • Copies of previous diagnoses and test results (bone marrow examination, genetic test results such as JAK2/CALR/MPL and BCR‑ABL, etc.)
    • Record of thrombosis or bleeding history (time of occurrence, site, and treatment course)
    • Symptom change diary (fatigue, night sweats, weight changes, feeling of fullness in the left upper abdomen, etc.)
  • Points to confirm on the day of the outpatient visit
    • Recent fever or infection, planned surgery or procedure, and whether you are pregnant or breastfeeding
    • Vaccinations (e.g., influenza and pneumococcal vaccines) and infection prevention status

Example questions (for patients to check themselves when making an outpatient appointment)

  • Have you recently had symptoms of thrombosis or bleeding?
  • Have you missed any doses of medication or started any new medications (e.g., antithrombotic or hormonal drugs)?

4) Examples of General Questions to Ask the Doctor

  • What is the expected course of this disease given my age and condition? (Prognosis)
  • What is the current target range for my blood cell counts, and what is the treatment plan for reaching the target?
  • What are the main side effects of the medication you plan to prescribe, and what needs to be monitored?
  • I am planning a pregnancy. Are there any recommendations to stop treatment or switch to an alternative treatment?
  • What precautions should I take regarding lifestyle habits (exercise, alcohol consumption, travel, etc.)?

5) Examples of Disease-Specific Questions

  • (If you have a history of thrombosis or are at high risk) Is aspirin alone sufficient to lower my risk of thrombosis, or do I need an anticoagulant or cytoreductive agent?
  • (For PMF or severe symptoms) Do I meet the indications for a bone marrow transplant, and when should I receive a transplant consultation?

Note: The diagnosis and treatment plan vary depending on the individual's clinical condition, genetic mutations, and comorbidities. Consult your doctor regarding specific prescriptions.

Patient stories: Hereditary spherocytosis

Talk with other Hereditary spherocytosis patientsAsk people who have been through itWrite

Hospitals that treat Hereditary spherocytosis

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Other conditions in Hematology and Oncology

Condition guide
Find top doctors for 'Hereditary spherocytosis'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →